(BLDR) Builders FirstSource - Ratings and Ratios
Lumber, Trusses, Panels, Windows, Doors, Millwork
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 46.1% |
| Value at Risk 5%th | 69.2% |
| Relative Tail Risk | -8.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.52 |
| Alpha | -42.07 |
| CAGR/Max DD | 0.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.442 |
| Beta | 1.082 |
| Beta Downside | 0.683 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.07% |
| Mean DD | 21.50% |
| Median DD | 19.83% |
Description: BLDR Builders FirstSource January 02, 2026
Builders FirstSource (BLDR) manufactures and distributes a broad portfolio of building-material products-including trusses, wall panels, doors, millwork, siding, and lumber-as well as turn-key framing and design-software services for professional homebuilders, remodelers, and light-commercial contractors across the United States.
In FY 2023 the company reported revenue of roughly **$5.9 billion**, an operating margin of **~6 %**, and a **3.2 %** same-store sales increase, reflecting steady demand despite elevated mortgage rates. The balance sheet remains solid, with a debt-to-EBITDA ratio near **3.5×**, giving the firm flexibility to fund its ongoing acquisition strategy.
Key economic drivers for BLDR are U.S. housing-starts trends (which fell 6 % YoY in Q4 2023) and the prevailing cost of financing; lower starts depress volume, while higher rates pressure builder margins and may shift demand toward cost-effective, pre-engineered solutions that BLDR offers. Additionally, supply-chain normalization for lumber and engineered wood products is expected to improve gross margins in 2024.
For a deeper, data-rich perspective on BLDR’s valuation and risk profile, you might explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 593.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -6.96 > 1.0 |
| NWC/Revenue: 9.27% < 20% (prev 9.06%; Δ 0.21% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.39b > Net Income 593.9m |
| Net Debt (4.78b) to EBITDA (1.61b): 2.98 < 3 |
| Current Ratio: 1.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (110.9m) vs 12m ago -5.14% < -2% |
| Gross Margin: 30.97% > 18% (prev 0.34%; Δ 3064 % > 0.5%) |
| Asset Turnover: 140.2% > 50% (prev 153.6%; Δ -13.35% > 0%) |
| Interest Coverage Ratio: 3.97 > 6 (EBITDA TTM 1.61b / Interest Expense TTM 259.2m) |
Altman Z'' 1.51
| A: 0.13 (Total Current Assets 3.30b - Total Current Liabilities 1.85b) / Total Assets 11.43b |
| B: 0.01 (Retained Earnings 122.4m / Total Assets 11.43b) |
| C: 0.09 (EBIT TTM 1.03b / Avg Total Assets 11.16b) |
| D: 0.02 (Book Value of Equity 123.5m / Total Liabilities 7.11b) |
| Altman-Z'' Score: 1.51 = BB |
Beneish M -3.05
| DSRI: 0.99 (Receivables 1.70b/1.83b, Revenue 15.65b/16.73b) |
| GMI: 1.08 (GM 30.97% / 33.55%) |
| AQI: 1.04 (AQ_t 0.47 / AQ_t-1 0.45) |
| SGI: 0.94 (Revenue 15.65b / 16.73b) |
| TATA: -0.07 (NI 593.9m - CFO 1.39b) / TA 11.43b) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
ValueRay F-Score (Strict, 0-100) 49.05
| 1. Piotroski: 5.50pt |
| 2. FCF Yield: 5.43% |
| 3. FCF Margin: 6.52% |
| 4. Debt/Equity: 1.18 |
| 5. Debt/Ebitda: 2.98 |
| 6. ROIC - WACC: 1.61% |
| 7. RoE: 13.84% |
| 8. Revenue Trend: -69.31% |
| 9. EPS Trend: -77.37% |
What is the price of BLDR shares?
Over the past week, the price has changed by -0.13%, over one month by +17.67%, over three months by -0.67% and over the past year by -29.48%.
Is BLDR a buy, sell or hold?
- Strong Buy: 11
- Buy: 5
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLDR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 131 | 7.1% |
| Analysts Target Price | 131 | 7.1% |
| ValueRay Target Price | 131.4 | 7.4% |
BLDR Fundamental Data Overview January 19, 2026
P/E Forward = 22.1239
P/S = 0.8957
P/B = 3.2484
P/EG = 0.81
Revenue TTM = 15.65b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.61b USD
Long Term Debt = 4.43b USD (from longTermDebt, last quarter)
Short Term Debt = 121.2m USD (from shortTermDebt, last quarter)
Debt = 5.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.78b USD (from netDebt column, last quarter)
Enterprise Value = 18.81b USD (14.02b + Debt 5.08b - CCE 296.2m)
Interest Coverage Ratio = 3.97 (Ebit TTM 1.03b / Interest Expense TTM 259.2m)
EV/FCF = 18.43x (Enterprise Value 18.81b / FCF TTM 1.02b)
FCF Yield = 5.43% (FCF TTM 1.02b / Enterprise Value 18.81b)
FCF Margin = 6.52% (FCF TTM 1.02b / Revenue TTM 15.65b)
Net Margin = 3.79% (Net Income TTM 593.9m / Revenue TTM 15.65b)
Gross Margin = 30.97% ((Revenue TTM 15.65b - Cost of Revenue TTM 10.81b) / Revenue TTM)
Gross Margin QoQ = 30.43% (prev 30.68%)
Tobins Q-Ratio = 1.65 (Enterprise Value 18.81b / Total Assets 11.43b)
Interest Expense / Debt = 1.36% (Interest Expense 69.3m / Debt 5.08b)
Taxrate = 23.28% (37.1m / 159.5m)
NOPAT = 789.2m (EBIT 1.03b * (1 - 23.28%))
Current Ratio = 1.79 (Total Current Assets 3.30b / Total Current Liabilities 1.85b)
Debt / Equity = 1.18 (Debt 5.08b / totalStockholderEquity, last quarter 4.32b)
Debt / EBITDA = 2.98 (Net Debt 4.78b / EBITDA 1.61b)
Debt / FCF = 4.69 (Net Debt 4.78b / FCF TTM 1.02b)
Total Stockholder Equity = 4.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.32% (Net Income 593.9m / Total Assets 11.43b)
RoE = 13.84% (Net Income TTM 593.9m / Total Stockholder Equity 4.29b)
RoCE = 11.80% (EBIT 1.03b / Capital Employed (Equity 4.29b + L.T.Debt 4.43b))
RoIC = 9.16% (NOPAT 789.2m / Invested Capital 8.62b)
WACC = 7.54% (E(14.02b)/V(19.10b) * Re(9.90%) + D(5.08b)/V(19.10b) * Rd(1.36%) * (1-Tc(0.23)))
Discount Rate = 9.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.34%
[DCF Debug] Terminal Value 76.50% ; FCFF base≈1.30b ; Y1≈1.06b ; Y5≈733.8m
Fair Price DCF = 90.30 (EV 14.77b - Net Debt 4.78b = Equity 9.99b / Shares 110.6m; r=7.54% [WACC]; 5y FCF grow -22.79% → 2.90% )
EPS Correlation: -77.37 | EPS CAGR: -49.97% | SUE: -3.90 | # QB: 0
Revenue Correlation: -69.31 | Revenue CAGR: -4.23% | SUE: 0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.90 | Chg30d=-0.033 | Revisions Net=-2 | Analysts=17
EPS next Year (2026-12-31): EPS=6.33 | Chg30d=-0.129 | Revisions Net=-2 | Growth EPS=-10.2% | Growth Revenue=-0.7%
Additional Sources for BLDR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle